High-Deductible Health Plans Linked to Delayed Diagnosis of Metastatic Cancer
Having a high-deductible health plan was associated with a nearly 5-month delay in the diagnosis of metastatic cancer.
Having a high-deductible health plan was associated with a nearly 5-month delay in the diagnosis of metastatic cancer.
This weekly series highlights eponyms in oncology. This week, we explore the history and namesakes of Peutz-Jeghers syndrome.
This weekly series highlights eponyms in oncology. This week, we explore the history and namesakes of von Hippel-Lindau disease.
This weekly series highlights eponyms in oncology. This week, we explore the history and namesake of the Bence-Jones protein.
The 2-year overall survival rate was 32.5%.
This weekly series highlights eponyms in oncology. This week, we explore the history and namesakes of Zollinger-Ellison syndrome.
Researchers found that, in 18% of recurrences, the new tumor was molecularly unrelated to the original tumor.
This weekly series highlights eponyms in oncology. This week, we explore the history and namesakes of Li-Fraumeni syndrome.
This weekly series highlights eponyms in oncology. This week, we explore the history and namesake of Lynch syndrome.
This weekly series highlights eponyms in oncology. This week, we explore the history and namesake of HeLa cells.